Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

INTRODUCTION: We have previously demonstrated that endoxifen is the most important tamoxifen metabolite responsible for eliciting the anti-estrogenic effects of this drug in breast cancer cells expressing estrogen receptor-alpha (ERα). However, the relevance of ERβ in mediating endoxifen action has...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xianglin, Subramaniam, Malayannan, Grygo, Sarah B, Sun, Zhifu, Negron, Vivian, Lingle, Wilma L, Goetz, Matthew P, Ingle, James N, Spelsberg, Thomas C, Hawse, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219188/
https://www.ncbi.nlm.nih.gov/pubmed/21392396
http://dx.doi.org/10.1186/bcr2844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219188/
https://www.ncbi.nlm.nih.gov/pubmed/21392396
http://dx.doi.org/10.1186/bcr2844

Ejemplares similares